Akeso gains NMPA approval for cadonilimab to treat cervical cancer
Cadonilimab is being evaluated in more than 30 Phase II and III clinical trials for other cancer conditions.
Cancer
ASCO25: J&J’s trispecific antibody shows 100% response in Phase I multiple myeloma study
Epsilogen acquires TigaTx to expand pan-isotope cancer antibody pipeline
NICE green lights two blood cancer therapies for NHS use
World Cancer Day: WHO warns of rising cancer burden in Southeast Asia
People-focused cancer care demands policy support
FDA expands Enhertu approval to include HER2-ultralow breast cancer patients
AstraZeneca gains NICE nod for lung cancer drugs Tagrisso and Imfinzi
